Mar 1, 2013 | Compliance, Legal, and Malpractice, Laboratory News, Laboratory Operations, Laboratory Pathology
Final Stage 2 rules give providers another year to meet Stage 1 ‘meaningful use’ criteria and shorten Stage 2 requirements from one-year to just 90 days
Clinical laboratory managers and pathologists may be interested to know that, over the fall months, the U.S. Department of Health and Human Services (HHS) released three new rules that affect users of health information technology (HIT).
One rule covers Stage Two of Meaningful Use and includes guidance on how providers should address the need to encrypt patient data. The second rule updates eligibility criteria that providers implementing electronic health record (EHR) systems must meet to qualify for federal incentives. Because medical laboratories and pathology groups maintain ongoing electronic interfaces with hospitals and office-based physicians, it is useful to know some of the key elements of these three recently issued federal regulations. The third rule establishes a date for conversion to ICD-10.
The new regulations were contained in a 1,354-page document published in the Federal Register. These rules represent “a tsunami of change” for providers, observed Patricia B. Wise, RN, MS, MA, COL (USA ret’d), Vice President for healthcare information systems for the Chicago-based Healthcare Information Exchange and Management Systems Society (HIMSS). Wise was quoted in a Modern Healthcare story. (more…)
Jan 4, 2013 | Digital Pathology, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Goals are to use whole gene sequencing to develop better clinical laboratory assays in support of personalized medicine
Creating new clinical laboratory tests to support personalized medicine is one goal of a unique collaboration recently announced that involves the pathology department at Beth Israel Deaconess Medical Center (BIDMC) and GenomeQuest, Inc. (NASDAQ:GQ). The two collaborators are expanding a relationship launched several years ago that involved doing whole genome sequencing of tumors.
More specifically, the expanded relationship will be a two-year collaboration to develop whole-genome analysis (WGA) applications for personalized medicine. The move signals pathologists and clinical laboratory managers that first movers are taking steps to address the growing need for clinical genomics informatics infrastructure.
“The plummeting cost of sequencing and the increasing volume of predictive, public studies makes the clinical application of genomics not just a practicality but a healthcare imperative,” declared GenomeQuest CEO Richard Resnick. “We believe that our collaboration with a combined innovation and delivery leader like BIDMC is a major step forward in expanding genomics and its rewards from the bench to the bedside.” (more…)
Dec 17, 2012 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
Pathologists are positioned to be the primary interpreters of big data as genomic medicine further evolves
Pathologists and clinical laboratory managers may be surprised to learn that at least one data scientist has proclaimed pathologists the real big data rock stars of healthcare. The reason has to do with the shift in focus of genomic medicine from therapeutics and presymptomatic disease assessment to big data analytics.
In a recent posting published at Forbes.com, data scientist Jim Golden heralded the pronouncement of Harvard pathologist Mark S. Boguski, M.D., Ph.D., FACM. He declared that “The time of the $1,000 genome meme is over!” (more…)
Sep 12, 2012 | Compliance, Legal, and Malpractice, Laboratory News, Laboratory Operations, Laboratory Pathology
Penalty program to reduce hospital inpatient readmissions could present an opportunity for pathologists and clinical laboratories
Remember the Medicare program that was designed to target hospital inpatient readmissions? The bill is coming due and Medicare penalties are soon to hit 2,211 of the nation’s hospitals. According to Kaiser Health News, as much as $280 million in penalties will be assessed against hospitals that did meet their goals.
The maximum penalty is 1% of a hospital’s base Medicare reimbursement. At least 278 hospitals will pay this maximum penalty, including some nationally-prominent institutions.
One consequence of these payment forfeitures is that hospital administration and physicians will be looking for ways to improve care and reduce the readmission rate for Medicare patients. In turn, it can be expected that clinicians will be motivated to pay closer attention to clinical laboratory test results in determining appropriate therapies and making discharge decisions. Utilization of medical laboratory tests may also improve as part of these overall efforts to improve patient outcomes and lower the rate of readmissions. (more…)
Feb 3, 2012 | Laboratory News, Laboratory Pathology
Patients are ready to ready access to their medical records; but physicians are wary
Data from two studies here in the United States affirms that patients want access to their health records. Consequently, health systems are increasingly making it easier for patients to get access to prescription lists, medical laboratory test results and now even doctors’ notes.
These findings are important for clinical laboratories and anatomic pathology groups. Laboratory test data typically makes up 70% of the information contained in patient’s health record. The growing interest on the part of patients to have access to their health records creates an opportunity for labs to add value by helping patients have access to their laboratory test results.
Of course, in providing that access, labs must comply with applicable laws governing patient privacy. They must also respect the relationship patients have with referring physicians and how those physicians are themselves allowing patients access to the health records they maintain in their medical practices.
(more…)
